- Delayed care and higher expenses for supplies, labor and drugs will result in hospitals losing about $54 billion in net income in 2021, even after taking into account relief provided under the Coronavirus Aid, Relief and Economic Security Act, according to an analysis released by the American Hospital Association.
- Without federal relief funds, hospitals would lose as much as $94 billion in 2021.
- The surge in COVID-19 hospitalizations among unvaccinated adults cost the U.S. health system $5.7 billion from June to August, according to a Kaiser Family Foundation analysis.
- The U.S. recently made two large deals totaling more than $3.5 billion with Regeneron and Eli Lilly to secure millions of additional doses of COVID-19 antibody drugs, as COVID-19 hospitalizations continue to rise in many parts of the country.
- As of August, 72 percent of the country’s largest health plans were no longer waiving out-of-pocket costs for COVID-19 treatment. A patient hospitalized for COVID-19 could incur out-of-pocket costs amounting to about $1,300, according to research released by the Peterson-KFF Health System Tracker.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
